The SROC curve indicated that CDK1 had a good capability in discriminating PCa samples from noncancer samples (AUC = 0.76; sensitivity = 0.70; and specificity = 0.71) (Figure 7(e)). The gene discussed is CDK1; the disease is posterior cortical atrophy.